author-photo

Clare Blenkinsop

University of Warwick

9

Papers

147

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

2017 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (13)
Abstract PD2-3: ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
The challenges of using radiological ‘tumour response' as an outcome: lessons learned from neo-tango and artemis, two neo-adjuvant chemotherapy breast cancer trials

2013 Trials
Show All
- Source
- Cite
- Save
Citations (0)
ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)